对SARS-CoV-2的抗尖峰单克隆抗体管道的更新
Daniele Focosi1, Massimo Franchini2, Arturo Casadevall3
1North-Western Tuscany Blood Bank, Pisa University Hospital, Pisa, Italy.
概括
新的抗尖端单克隆抗体正在为COVID-19开发,但它们对新出现的变种如JN.1的有效性尚不确定. 进一步的研究和开发对于基于抗体的疗法至关重要.
科学领域:
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 针对尖端蛋白的单克隆抗体对于预防和治疗COVID-19非常有价值,特别是在脆弱人群中.
- 奥米克朗变种的进化使现有的抗尖峰单克隆抗体变得无效.
- 目前的管道集中在新型抗体候选人,以克服病毒耐药性.
研究的目的:
- 审查当前抗尖峰单克隆抗体开发的现状.
- 识别和讨论临床管道中的有前途的候选人.
- 评估对当前和新出现的SARS-CoV-2变种的潜在疗效.
主要方法:
- 在PubMed和ClinicalTrials.gov.gov的系统文献搜索.
- 对正在进行的研究进行制造商新闻稿的分析.
- 对特定抗体候选者的临床进展数据的审查.
主要成果:
- 几种新的抗尖峰单克隆抗体正在临床开发中,包括AZD3152,VYD222,REGN-17092和AER-800.
- 目前临床管道有限,重点是单个抗体剂.
- 对于这些新药,对占主导地位的JN.1亚系的有效性数据仍然在很大程度上是未知的.
结论:
- 开发有效的抗尖峰单克隆抗体面临着由于病毒快速演变的挑战.
- 目前的管道有希望,但需要对流行SARS-CoV-2菌株进行进一步验证.
- 需要增加制造商和研究机构的投资,以推进基于抗体的COVID-19疗法.
关键词:
AZD315222 的时间.AZD395999 的时间.有效性 有效性.单克隆抗体是一种单克隆抗体.美国1792年法令这就是SARS-CoV-2病毒.安全的安全的安全的安全的安全.斯派克斯派克斯派克斯派克斯是什么意思VYD222222 这是一个很大的问题.更多相关视频
相关概念视频
01:28Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
01:28Drug Products: Biologics, Biosimilars and Interchangeables
Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...